SLS — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
SELLAS Life Sciences Group, Inc.
Healthcare · $7.15
1.0
/10
Poor Entry
Put-selling entry timing — not a quality rating.A strong long-term holding can still show a low score today (thin premium, extended trend, or turning momentum).
How this score works → Try the calculator ↓
Regime
Bullish
vs SMA200
SMA200 Distance
+92.0%
Above trend
Volatility
High
Rich premiums
Momentum
Decelerating
6th day
About SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences is a clinical-stage biotech developing cancer immunotherapies. High beta, no dividend, binary Phase 3 trial catalyst risk. CSP premiums appear rich but extreme event risk from trial readouts makes selling very dangerous. Micro-cap with thin liquidity.
Biotechnology
Market Cap
$1.4B
P/E Ratio
Beta
2.53
Forward P/E
-47.7
52-Week Range Current: $7.15
$1.39 $9.51
Earnings
2026-08-11
61 days away

SLS — at 92.0% above its 200-day average, mean-reversion sits inside the typical CSP window. Under that condition, the 200-day reference is a more relevant strike anchor than current price.

Based on end-of-day market dataScored by ThetaLoop Research
SLS ranks #13 of 66 Healthcare tickers by put-selling score (622 total screened)

Position Size & Yield Calculator

Live model for SLS — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
APT Alpha Pro Tech, Ltd. 5.9 RZLV Rezolve AI PLC 5.0 ATYR aTyr Pharma, Inc. 4.1 BSX Boston Scientific Corporation 4.0 NVAX Novavax, Inc. 3.2 Browse all Healthcare tickers →
📌 Embed this score on your blog
The SLS X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/SLS" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/SLS">SLS X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Full Research Track Record — All Wins AND Losses
Cash-Secured Puts ↗ · See a sample →